AstraZeneca, Broad Institute in infectious deal

AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered with the Broad Institute of MIT and Harvard to discover antibacterials and antivirals. Under the two-year deal, the institute will use its chemical librar...